Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABHD16A | O95870 | 2/20 | 0.67 |
| ▸ | LPL | P06858 | 1/20 | 0.61 |
| ▸ | LIPC | P11150 | 1/20 | 0.61 |
| ▸ | LIPE | Q05469 | 1/20 | 0.61 |
| ▸ | MGLL | Q99685 | 3/20 | 0.60 |
| ▸ | FAAH | O00519 | 3/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | MAPKAPK2 | P49137 | 2/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
| ▸ | PARP1 | P09874 | 1/20 | 0.45 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.45 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.45 |
| ▸ | PARP4 | Q9UKK3 | 1/20 | 0.45 |
| ▸ | ABHD6 | Q9BV23 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6601668 | 0.84 | ABHD16A (0.54) | ABHD16ALPLLIPCLIPEMGLL | |
| SCHEMBL7046228 | 0.83 | ABHD16A (0.72) | ABHD16ALPLLIPCLIPEMGLL | |
| SCHEMBL2233598 | 0.80 | ABHD16A (0.72) | ABHD16ALPLLIPCLIPEMGLL | |
| SCHEMBL2233406 | 0.80 | ABHD16A (0.72) | ABHD16ALPLLIPCLIPEMGLL | |
| SCHEMBL11620781 | 0.80 | FAAH (0.78) | ABHD16ALPLLIPCLIPEMGLL | |
| SCHEMBL6551854 | 0.78 | FAAH (0.74) | ABHD16ALPLLIPCLIPEMGLL | |
| SCHEMBL7047919 | 0.77 | LPL (1.00) | ABHD16ALPLLIPCLIPEMGLL | |
| SCHEMBL2237968 | 0.75 | ABHD16A (0.72) | ABHD16ALPLLIPCLIPEMGLL | |
| SCHEMBL6552566 | 0.75 | MGLL (1.00) | ABHD16AMGLLFAAH | |
| SCHEMBL7044266 | 0.75 | LPL (0.70) | ABHD16ALPLLIPCLIPEMGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1482929-A1 | USE OF SUBSTITUTED 3-PHENYL-5-ALKOXY-1,3,4-OXDIAZOLE-2-ONE FOR PRODUCING MEDICAMENTS THAT INHIBIT PANCREATIC LIPASE | Aventis Pharma Deutschland GmbH (DE) | 2004-12-08 | — | — | EP | disclosed |
| EP-1263745-B1 | SUBSTITUTED 3-PHENYL-5-ALKOXI-1,3,4-OXDIAZOL-2-ONE AND USE THEREOF FOR INHIBITING HORMONE-SENSITIVE LIPASE | AVENTIS PHARMA GMBH (DE) | 2004-05-19 | — | — | EP | disclosed |
| WO-2003072098-A1 | USE OF SUBSTITUTED 3-PHENYL-5-ALKOXY-1,3,4-OXDIAZOLE-2-ONE FOR PRODUCING MEDICAMENTS THAT INHIBIT PANCREATIC LIPASE | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2003-09-04 | — | — | WO | disclosed |
| EP-1263745-A1 | SUBSTITUTED 3-PHENYL-5-ALKOXI-1,3,4-OXDIAZOL-2-ONE AND USE THEREOF FOR INHIBITING HORMONE-SENSITIVE LIPASE | Aventis Pharma Deutschland GmbH (DE) | 2002-12-11 | — | — | EP | disclosed |
| US-6369088-B2 | ANTIDIABETIC AGENTS | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2002-04-09 | — | — | US | disclosed |
| WO-2001066531-A1 | SUBSTITUTED 3-PHENYL-5-ALKOXI-1,3,4-OXDIAZOL-2-ONE AND USE THEREOF FOR INHIBITING HORMONE-SENSITIVE LIPASE | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2001-09-13 | — | — | WO | disclosed |